StockData
Bone Biologics Corp logo

Bone Biologics Corp (BBLG) stock

BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)

Close on Nov 18, 2026Market cap $986.22KP/E –Yield –

Bone Biologics cash

Cash and short-term investments held at the end of each period.

Bone Biologics's cash was $6.09M at Sep 30, 2026. For fiscal 2025 it was $5.33M, up 60.4% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $7.54M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.33M+60.4%
FY2024Dec 31, 2024$3.33M+9.9%
FY2023Dec 31, 2023$3.03M-59.9%
FY2022Dec 31, 2022$7.54M+12.9%
FY2021Dec 31, 2021$6.68M+27547.0%
FY2019Dec 31, 2019$24.15K-97.5%
FY2018Dec 31, 2018$955.37K+38.4%
FY2017Dec 31, 2017$690.28K+11.3%
FY2016Dec 31, 2016$620.38K-44.4%
FY2015Dec 31, 2015$1.12M-58.1%
FY2014Dec 31, 2014$2.66M+532179.2%
FY2012Oct 31, 2012$500–
FY2011Oct 31, 2011$0–
FY2010Oct 31, 2010$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$6.09M+0.6%
Q2 FY2026Jun 30, 2026$4.03M-39.3%
Q1 FY2026Mar 31, 2026$4.53M+64.9%
Q4 FY2025Dec 31, 2025$5.33M+60.4%
Q3 FY2025Sep 30, 2025$6.05M+69.6%
Q2 FY2025Jun 30, 2025$6.64M+184.7%
Q1 FY2025Mar 31, 2025$2.75M-14.9%
Q4 FY2024Dec 31, 2024$3.33M+9.9%
Q3 FY2024Sep 30, 2024$3.57M-19.9%
Q2 FY2024Jun 30, 2024$2.33M-66.7%
Q1 FY2024Mar 31, 2024$3.23M-47.8%
Q4 FY2023Dec 31, 2023$3.03M-59.9%
Q3 FY2023Sep 30, 2023$4.45M-18.4%
Q2 FY2023Jun 30, 2023$7.01M+20.5%
Q1 FY2023Mar 31, 2023$6.19M-7.3%
Q4 FY2022Dec 31, 2022$7.54M+223323.6%
Q2 FY2022Jun 30, 2022$5.45M+122805.0%
Q1 FY2022Mar 31, 2022$5.81M+8070.6%
Q4 FY2021Dec 31, 2021$6.68M+271146.0%
Q3 FY2021Sep 30, 2021$3.37K+38.7%
Q2 FY2021Jun 30, 2021$4.44K-81.6%
Q1 FY2021Mar 31, 2021$71.17K-64.7%
Q3 FY2020Sep 30, 2020$2.46K-98.6%
Q1 FY2020Mar 31, 2020$2.43K-99.7%
Q4 FY2019Dec 31, 2019$24.15K-97.5%
Q3 FY2019Sep 30, 2019$201.83K-91.2%
Q2 FY2019Jun 30, 2019$176.37K-42.1%
Q1 FY2019Mar 31, 2019$726.41K+95.6%
Q4 FY2018Dec 31, 2018$955.37K+38.4%
Q3 FY2018Sep 30, 2018$2.29M+41.4%
Q2 FY2018Jun 30, 2018$304.56K-61.1%
Q1 FY2018Mar 31, 2018$371.40K-77.0%
Q4 FY2017Dec 31, 2017$690.28K+11.3%
Q3 FY2017Sep 30, 2017$1.62M+135.7%
Q2 FY2017Jun 30, 2017$783.01K–
Q1 FY2017Mar 31, 2017$1.61M–
Q4 FY2016Dec 31, 2016$620.38K–
Q3 FY2016Sep 30, 2016$688.23K–

More Bone Biologics figures

See a number that looks wrong?